科研级 Tucotuzumab( 西莫白介素单抗 ), Anti-CD326 Recombinant Antibody, Research Grade Tucotuzumab
Molecular Name
Tucotuzumab
Size
¥500/100ug, ¥3200/1mg, ¥6800/5mg, 定制报价/10mg以上
CAS Number
339986-90-2
Isotype
IgG1
Clonality
Monoclonal
Concentration
1mg/ml
Source
CHO Cells
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
EPCAM/CD326[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Tucotuzumab celmoleukin is an anti-cancer drug. It is a fusion protein of a humanized monoclonal antibody (tucotuzumab) and an interleukin-2 (celmoleukin). This drug was developed by EMD Pharmaceuticals.